Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hologic Inc (NASDAQ:HOLX)

40.82
Delayed Data
As of Feb 24
 +0.52 / +1.29%
Today’s Change
32.64
Today|||52-Week Range
41.24
+1.74%
Year-to-Date
Medtronic Earnings Rebound in Third Quarter, Shares Climb
Feb 21 / TheStreet.com - Paid Partner Content
Here's Why Cynosure, Inc. is Soaring Today
Feb 14 / MotleyFool.com - Paid Partner Content
Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal
Feb 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close40.30
Today’s open40.34
Day’s range40.20 - 40.83
Volume2,309,211
Average volume (3 months)2,569,145
Market cap$11.4B
Dividend yield--
Data as of 4:15pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+157.78%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)+9.76%
Revenue growth (last year)+4.72%
P/E ratio34.9
Price/Sales3.88
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
VREXVarex Imaging Corp+0.67+1.97%
ALOGAnalogic Corp-0.40-0.49%
VRAYViewray Inc+0.01+0.21%
GTHPGuided Therapeutics ...-0.05-8.47%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.46
Annual revenue (last year)$2.8B
Annual profit (last year)$330.8M
Net profit margin11.68%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Stephen P. MacMillan
Chief Operating Officer
Eric B. Compton
Corporate headquarters
Marlborough, Massachusetts

Forecasts


Search for Jobs